We are live on ! Find out more
RCA

Rex Capital Advisors Portfolio holdings

AUM $152M
1-Year Est. Return 17.51%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
-17.51%
3 Year Est. Return
+7.31%
5 Year Est. Return
+24.45%
10 Year Est. Return
–
AUM
$190M
AUM Growth
-$3.74M
Cap. Flow
+$5.31M
Cap. Flow %
2.8%
Top 10 Hldgs %
96.88%
Holding
26
New
5
Increased
5
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.57M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.38M
3
ABOS icon
Acumen Pharmaceuticals
ABOS
+$718K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$634K
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$554K

Top Sells

Rank Stock Value
1
ARKF icon
ARK Blockchain & Fintech Innovation ETF
ARKF
+$652K
2
ARKG icon
ARK Genomic Revolution ETF
ARKG
+$534K
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$286K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.63%
2 Financials 1.54%
3 Industrials 0.81%
4 Technology 0.74%
5 Real Estate 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARKG icon
26
ARK Genomic Revolution ETF
ARKG
$1.51B
– –
-7,142
Closed -$534K
1
2

Similar funds

RCC
Red Cedar Capital Omaha, Nebraska $158M AUM 6.57% 1-Year Est. Return
BFS
Bickling Financial Services Lexington, Massachusetts $160M AUM 18.81% 1-Year Est. Return
AWM
Aevitas Wealth Management Wellesley Hills, Massachusetts $169M AUM 9.55% 1-Year Est. Return
CCM
Cribstone Capital Management Augusta, Maine $172M AUM 13.58% 1-Year Est. Return
TS
True Signal New York $133M AUM
BA
Bennicas & Associates Portola Valley, California $173M AUM 1.55% 1-Year Est. Return
SAM
Stewart Asset Management New York $130M AUM 26.66% 1-Year Est. Return
S
Schroders London, United Kingdom $185M AUM 16.04% 1-Year Est. Return

Rex Capital Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Rex Capital Advisors held 26 positions worth $190M, down 1.9% from $194M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Rex Capital Advisors's Q4 2021 filing shows 5 new, 5 increased, 1 reduced and 2 closed positions. Its largest new stake was Acumen Pharmaceuticals: 65,336 shares worth $442K. The largest sale was ARK Blockchain & Fintech Innovation ETF, an estimated $652K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 24% a quarter earlier, followed by Financials and Industrials.

  • Rex Capital Advisors's largest Q4 2021 buy was Acumen Pharmaceuticals: 65,336 shares worth $442K.
  • Rex Capital Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $1.57M increase.
  • Rex Capital Advisors's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $286K.
  • Rex Capital Advisors fully exited ARK Blockchain & Fintech Innovation ETF in Q4 2021, selling an estimated $652K.
  • Rex Capital Advisors's ten largest holdings make up 97% of its $190M portfolio in Q4 2021.
  • Rex Capital Advisors opened 5 new positions and closed 2 in Q4 2021.
  • Rex Capital Advisors's portfolio value fell 1.9% quarter-over-quarter to $190M.

Based on Rex Capital Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.